INSULET CORP cotiza a 135.28 USD y tiene una capitalización bursátil de $9.4B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in …
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $1.66 | $1.42 | $1.55 |
| Estimado | $1.59 | $1.45 | $1.19 | $1.46 |
| Sorpresa | — | +14.5% | +19.3% | +6.2% |
| Métrica | PODD | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 71.6% | 57.0% | +14.6% |
| Operating Margin | 17.5% | -38.6% | +56.1% |
| Net Margin | 9.1% | -33.6% | +42.7% |
| FCF Margin | 13.9% | -13.9% | +27.8% |
| ROE | 16.3% | -40.4% | +56.7% |
| ROA | 7.8% | -32.0% | +39.8% |
| Current Ratio | 2.81 | 2.84 | -0.03 |
| Debt / Equity | 0.61 | 0.28 | +0.33 |